TMJ FOSSA-EMINENCE PROSTHESIS(TM)

FDA Premarket Approval P000035

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the tmj fossa-eminence prosthesis(tm). The device is indicated for use in treatment of severe temporomandibular joint disease due to: 1) inflammatory arthritis involving the temporomandibular joint not responsive to other modalities of treatment, 2) recurrent fibrosis and/or bony ankylosis not responsive to other modalities of treatment, 3) failed tissue graft, 4) failed alloplastic joint reconstruction, 5) internal derangement confirmed to be pathological in origin by both clinical observation and radiographic findings, where the patient has moderate to severe pain and/or disabling dysfunction and has not responded to less invasive conventional therapy.

DeviceTMJ FOSSA-EMINENCE PROSTHESIS(TM)
Generic NameGlenoid Fossa Prosthesis
ApplicantNEXUS CMF, LLC
Date Received2000-06-20
Decision Date2001-02-27
Notice Date2001-05-14
PMAP000035
SupplementS
Product CodeMPI 
Docket Number01M-0210
Advisory CommitteeDental
Expedited ReviewNo
Combination Product No
Applicant Address NEXUS CMF, LLC 17301 West Colfax Avenue suite 170 golden, CO 80401
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P000035Original Filing
S011 2015-01-16 30-day Notice
S010 2014-05-02 30-day Notice
S009 2014-03-04 Real-time Process
S008 2012-05-03 135 Review Track For 30-day Notice
S007 2011-08-29 Normal 180 Day Track No User Fee
S006 2011-05-11 Normal 180 Day Track No User Fee
S005
S004 2002-12-26 Normal 180 Day Track
S003 2002-06-20 Normal 180 Day Track
S002 2002-06-20 Normal 180 Day Track
S001 2002-06-18 Normal 180 Day Track

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.